Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases

Background. Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcareassociated outbreaks. Here, we describe 34 cases of pediatric C. auris bloodstream infections (BSIs) identified during July 2014– October 2017 in 2 hospitals in Colombia. Methods. We c...

Full description

Autores:
Berrio, Indira
Caceres, Diego H.
Coronell R, Wilfrido
Salcedo, Soraya
Mora, Laura
Marin, Adriana
Varón, Carmen
Lockhart, Shawn R.
Escandón, Patricia
Berkow, Elizabeth L.
Rivera, Sandra
Chiller, Tom
Vallabhaneni, Snigdha
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad Simón Bolívar
Repositorio:
Repositorio Digital USB
Idioma:
eng
OAI Identifier:
oai:bonga.unisimon.edu.co:20.500.12442/5708
Acceso en línea:
https://hdl.handle.net/20.500.12442/5708
https://doi.org/10.1093/jpids/piaa038
Palabra clave:
Bloodstream infections
Candida auris
Children
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
id USIMONBOL2_b5867bc85e2a48a90ce00ea0c92f7a6e
oai_identifier_str oai:bonga.unisimon.edu.co:20.500.12442/5708
network_acronym_str USIMONBOL2
network_name_str Repositorio Digital USB
repository_id_str
dc.title.eng.fl_str_mv Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
title Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
spellingShingle Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
Bloodstream infections
Candida auris
Children
title_short Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
title_full Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
title_fullStr Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
title_full_unstemmed Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
title_sort Bloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Cases
dc.creator.fl_str_mv Berrio, Indira
Caceres, Diego H.
Coronell R, Wilfrido
Salcedo, Soraya
Mora, Laura
Marin, Adriana
Varón, Carmen
Lockhart, Shawn R.
Escandón, Patricia
Berkow, Elizabeth L.
Rivera, Sandra
Chiller, Tom
Vallabhaneni, Snigdha
dc.contributor.author.none.fl_str_mv Berrio, Indira
Caceres, Diego H.
Coronell R, Wilfrido
Salcedo, Soraya
Mora, Laura
Marin, Adriana
Varón, Carmen
Lockhart, Shawn R.
Escandón, Patricia
Berkow, Elizabeth L.
Rivera, Sandra
Chiller, Tom
Vallabhaneni, Snigdha
dc.subject.eng.fl_str_mv Bloodstream infections
Candida auris
Children
topic Bloodstream infections
Candida auris
Children
description Background. Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcareassociated outbreaks. Here, we describe 34 cases of pediatric C. auris bloodstream infections (BSIs) identified during July 2014– October 2017 in 2 hospitals in Colombia. Methods. We conducted a retrospective review of microbiology records for possible C. auris cases in 2 hospitals in Barranquilla and Cartagena. BSIs that occurred in patients aged <18 years confirmed as C. auris were included in this analysis. Results. We identified 34 children with C. auris BSIs. Twenty-two (65%) patients were male, 21% were aged <28 days, 47% were aged 29–365 days, and 32% were aged >1 year. Underlying conditions included preterm birth (26%), being malnourished (59%), cancer (12%), solid-organ transplant (3%), and renal disease (3%). Eighty-two percent had a central venous catheter (CVC), 82% were on respiratory support, 56% received total parenteral nutrition (TPN), 15% had a surgical procedure, and 9% received hemodialysis. Preinfection inpatient stay was 22 days (interquartile range, 19–33 days), and in-hospital mortality was 41%. Conclusions. Candida auris affects children with a variety of medical conditions including prematurity and malignancy, as well as children with CVCs and those who receive TPN. Mortality was high, with nearly half of patients dying before discharge. However, unlike most other Candida species, C. auris can be transmitted in healthcare settings, as suggested by the close clustering of cases in time at each of the hospitals.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-05-21T17:33:48Z
dc.date.available.none.fl_str_mv 2020-05-21T17:33:48Z
dc.date.issued.none.fl_str_mv 2020
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.eng.fl_str_mv article
dc.identifier.issn.none.fl_str_mv 20487207
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12442/5708
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1093/jpids/piaa038
identifier_str_mv 20487207
url https://hdl.handle.net/20.500.12442/5708
https://doi.org/10.1093/jpids/piaa038
dc.language.iso.eng.fl_str_mv eng
language eng
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.spa.fl_str_mv pdf
dc.publisher.eng.fl_str_mv Oxford University Press
dc.source.eng.fl_str_mv Journal of the Pediatric Infectious Diseases Society
institution Universidad Simón Bolívar
bitstream.url.fl_str_mv https://bonga.unisimon.edu.co/bitstreams/8c01ba26-51d5-455d-9bd9-c4b7e38627da/download
https://bonga.unisimon.edu.co/bitstreams/b20f406b-56cd-4628-a5a8-e3a5fe54c32e/download
bitstream.checksum.fl_str_mv 4460e5956bc1d1639be9ae6146a50347
733bec43a0bf5ade4d97db708e29b185
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositorio Digital Universidad Simón Bolívar
repository.mail.fl_str_mv repositorio.digital@unisimon.edu.co
_version_ 1812100515820994560
spelling Berrio, Indira64acd5c4-0851-4041-967a-9b19b8f00f14Caceres, Diego H.fef1522c-1e63-4955-ab32-3b066088773bCoronell R, Wilfridob2cb1905-977a-43ef-948b-d6abfc715a9dSalcedo, Sorayab86a56c3-642d-4c35-a2a4-7870968943c2Mora, Laura25541f1b-7b29-489c-a661-90a1a059f6bdMarin, Adriana85c7f341-b950-4361-8581-0371338b62fbVarón, Carmen6e8751c0-54ce-4ca1-81c3-a403c6a430c6Lockhart, Shawn R.7597ee67-f522-4189-9dc4-23f998211e74Escandón, Patricia261f4477-53c1-47eb-9592-a6f6e424a316Berkow, Elizabeth L.ded5c767-8742-4b0a-a3f7-57b745017ce3Rivera, Sandrae8c0da35-c5dd-4a1c-994d-f0b6cc9bae88Chiller, Tom8d45f5be-269c-4c3d-813e-43f7a20ea78cVallabhaneni, Snigdha4e717539-3212-409a-b9ad-c8583dcb5c982020-05-21T17:33:48Z2020-05-21T17:33:48Z202020487207https://hdl.handle.net/20.500.12442/5708https://doi.org/10.1093/jpids/piaa038Background. Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcareassociated outbreaks. Here, we describe 34 cases of pediatric C. auris bloodstream infections (BSIs) identified during July 2014– October 2017 in 2 hospitals in Colombia. Methods. We conducted a retrospective review of microbiology records for possible C. auris cases in 2 hospitals in Barranquilla and Cartagena. BSIs that occurred in patients aged <18 years confirmed as C. auris were included in this analysis. Results. We identified 34 children with C. auris BSIs. Twenty-two (65%) patients were male, 21% were aged <28 days, 47% were aged 29–365 days, and 32% were aged >1 year. Underlying conditions included preterm birth (26%), being malnourished (59%), cancer (12%), solid-organ transplant (3%), and renal disease (3%). Eighty-two percent had a central venous catheter (CVC), 82% were on respiratory support, 56% received total parenteral nutrition (TPN), 15% had a surgical procedure, and 9% received hemodialysis. Preinfection inpatient stay was 22 days (interquartile range, 19–33 days), and in-hospital mortality was 41%. Conclusions. Candida auris affects children with a variety of medical conditions including prematurity and malignancy, as well as children with CVCs and those who receive TPN. Mortality was high, with nearly half of patients dying before discharge. However, unlike most other Candida species, C. auris can be transmitted in healthcare settings, as suggested by the close clustering of cases in time at each of the hospitals.pdfengOxford University PressAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_16ecJournal of the Pediatric Infectious Diseases SocietyBloodstream infectionsCandida aurisChildrenBloodstream infections with Candida auris among children in Colombia: Clinical characteristics and outcomes of 34 Casesarticlearticlehttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Forsberg K, Woodworth K, Walters M, et al. Erratum: Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol 2019; 57:e7.Benedict K, Roy M, Kabbani S, et al. Neonatal and pediatric candidemia: results from population-based active laboratory surveillance in four US locations, 2009– 2015. J Pediatric Infect Dis Soc 2018; 7:e78–85.Tsay S, Welsh RM, Adams EH, et al.; MSD. Notes from the field: ongoing transmission of Candida auris in health care facilities—United States, June 2016–May 2017. MMWR Morb Mortal Wkly Rep 2017; 66:514–5.Eyre DW, Sheppard AE, Madder H, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 2018; 379:1322–31.Recommendations for identification of Candida auris. 2018. Available at: https://www.cdc.gov/fungal/candida-auris/recommendations.html. Accessed 16 October 2019.Escandón P, Chow NA, Caceres DH, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis 2019; 68:15–21.Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis 2017; 23:162–4.Calvo B, Melo AS, Perozo-Mena A, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 2016; 73:369–74.Chowdhary A, Sharma C, Duggal S, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 2013; 19:1670–3.Lockhart SR, Jackson BR, Vallabhaneni S, et al. Thinking beyond the common Candida species: need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris. J Clin Microbiol 2017; 55:3324–7.CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://bonga.unisimon.edu.co/bitstreams/8c01ba26-51d5-455d-9bd9-c4b7e38627da/download4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8381https://bonga.unisimon.edu.co/bitstreams/b20f406b-56cd-4628-a5a8-e3a5fe54c32e/download733bec43a0bf5ade4d97db708e29b185MD5320.500.12442/5708oai:bonga.unisimon.edu.co:20.500.12442/57082024-08-14 21:54:05.596http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internacionalmetadata.onlyhttps://bonga.unisimon.edu.coRepositorio Digital Universidad Simón Bolívarrepositorio.digital@unisimon.edu.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